Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1)

Basit Öğe Kaydı
dc.authoridArat, Mutlu/0000-0003-2039-8557
dc.authoridSaltoglu, Nese/0000-0003-4239-9585
dc.authoridKalayoglu Besisik, Sevgi/0000-0002-9310-1278
dc.authorwosidArat, Mutlu/AAI-1481-2019
dc.authorwosidBesısık, Sevgi/AAD-6628-2020
dc.authorwosidSALTOGLU, NESE/AAJ-5552-2021
dc.authorwosidSalto?lu, Neşe/AAV-2262-2021
dc.authorwosidSaltoglu, Nese/E-2833-2019
dc.authorwosidÇağatay, Atahan/AAE-2343-2020
dc.authorwosidAkalin, Halis/AAU-8952-2020
dc.contributor.authorAkan, Hamdi
dc.contributor.authorAydin, Seniz Ongoren
dc.contributor.authorSaltoglu, Nese
dc.contributor.authorCagatay, Atahan
dc.contributor.authorAkalin, Halis
dc.contributor.authorArat, Mutlu
dc.contributor.authorAli, Ridvan
dc.date.accessioned2024-06-12T11:03:59Z
dc.date.available2024-06-12T11:03:59Z
dc.date.issued2014
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe introduction of novel antifungal agents for the treatment of invasive fungal disease in hematological malignancies and also changing treatment strategies have had a great impact in managing affected patients. The medical literature includes some important clinical studies that are being used as evidence for guidelines. The problem with these studies and the guidelines is that they are not very easy to interpret, they include controversial issues, and they are not easy to apply to every patient or country. This paper was designed to critically show the main problems associated with these approaches and provide important information that will help Turkish doctors to adopt them in daily clinical practice.en_US
dc.identifier.doi10.4274/tjh.2014.0103
dc.identifier.endpage120en_US
dc.identifier.issn1300-7777
dc.identifier.issn1308-5263
dc.identifier.issue2en_US
dc.identifier.pmid25035667en_US
dc.identifier.scopus2-s2.0-84905912115en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage111en_US
dc.identifier.urihttps://doi.org/10.4274/tjh.2014.0103
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21870
dc.identifier.volume31en_US
dc.identifier.wosWOS:000338094600001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofTurkish Journal Of Hematologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectInvasive Fungal Infectionen_US
dc.subjectAntifungal Treatmenten_US
dc.subjectEvidenceen_US
dc.subjectHematological Malignanciesen_US
dc.subjectLiposomal Amphotericin-Ben_US
dc.subjectPreemptive Antifungal Therapyen_US
dc.subjectNeutropenic Patientsen_US
dc.subjectEmpirical-Treatmenten_US
dc.subjectPersistent Feveren_US
dc.subjectHigh-Risken_US
dc.subjectFebrileen_US
dc.subjectAmbisomeen_US
dc.subjectVoriconazoleen_US
dc.subjectEfficacyen_US
dc.titleRecommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu